Patients with moderate-to-severe uncontrolled asthma treated with the ezcema drug dupilumab have achieved significantly lower rates of severe asthma exacerbation than those using a placebo. Researchers reported this… read more.
The growing number of novel treatments for multiple myeloma (MM) means that more patients can achieve the therapeutic goal of a deep and prolonged first remission – in… read more.
Men who have received initial treatment for prostate cancer with abiraterone added to hormone therapy achieved a survival rate 37 per cent higher than those not treated with… read more.
By Maria Dalby (article) and Esther Drain (interviews) Even in an era of rapid progress in terms of new agents and treatment approaches, stem cell transplantation (SCT) continues… read more.
By Maria Dalby (article) and Esther Drain (interviews) Not only is the treatment ‘landscape’ in Hodgkin lymphoma (HL) changing rapidly both in the first-line and relapsed/refractory setting, but… read more.
by Gary Finnegan: A clear trend towards lighter drinking among young people is responsible for reversing years of rising alcohol intake, according to new research. Experts hope this… read more.
by Bruce Sylvester: Platelet transfusion after acute spontaneous primary intracerebral haemorrhage in people taking antiplatelet therapy appears to be less effective than standard care, researchers reported on June… read more.
Increased mortality when blood came from young and female donors. Transfusion recipients getting red blood cell (RBC) units from younger and/or female donors had increased mortality, results of… read more.
Within the past 10 years, the prescription of opioids for the treatment of chronic pain has increased and the abuse of opioid medications leading to addiction has been… read more.
by Bruce Sylvester: There is no decrease in hospital length of stay among patients hospitalized with acute respiratory failure who have received standardized rehabilitation therapy rather than usual… read more.
Consolidation and maintenance therapy for multiple myeloma: is it the new standard? Professor Antonio Palumbo (University of Turin, Italy) and Professor Paul Richardson (Harvard Medical School, Boston,… read more.
How monoclonal antibodies will change the treatment of multiple myeloma by Maria Dalby Philippe Moreau, University Hospital Hôtel-Dieu, Nantes, France Meletios Dimopoulos, University of Athens School of… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
